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O B J E C T I V E S This study sought to test the hypothesis that transmural perfusion gradients (TPG) on
adenosine stress myocardial perfusion cardiac magnetic resonance (CMR) predict hemodynamically
signiﬁcant coronary artery disease (CAD) as deﬁned by fractional ﬂow reserve (FFR).
B A C KG ROUND Myocardial ischemia affects the subendocardial layers of the left ventricular myocar-
dium earlier and more severely than the outer layers, and the identiﬁcation of TPG should be sensitive and
speciﬁc for the diagnosis of CAD. Previous studies have shown that high spatial resolution myocardial
perfusion CMR allows quantitation of TPG between the subendocardium and the subepicardium.
METHOD S Sixty-seven patients (53 men, age 61  9 years) underwent coronary angiography and
high-resolution (1.2  1.2-mm in-plane) adenosine stress perfusion CMR at 3.0-T. TPG was calculated for
3 coronary territories. Visual analysis was performed to identify myocardial ischemia. FFR was measured
in all vessels with 50% severity stenosis. FFR 0.8 was considered hemodynamically signiﬁcant. In a
training group of 30 patients, the optimal threshold of TPG to detect signiﬁcant CAD was determined
(Group 1). This threshold was then tested prospectively in the remaining 37 patients (Group 2).
R E S U L T S In Group 1, a 20% TPG provided the best diagnostic threshold on both per-segment and
per-patient analysis. Applied to Group 2, this threshold yielded a sensitivity of 0.78, speciﬁcity of 0.94, and area
under the curve of 0.86 for the detection of CAD in a per-segment analysis and of 0.89, 0.83, and 0.86 in a
per-patient analysis, respectively. TPG had a similar diagnostic accuracy to visual assessment. Linear
regression analysis showed a relationship between TPG and FFR values, with r  0.63 (p  0.001).
CONC L U S I O N S The quantitative analysis of transmural perfusion gradients on high-resolution
myocardial perfusion CMR accurately predicts hemodynamically signiﬁcant CAD as deﬁned by FFR. A
TPG diagnostic threshold of 20% is as accurate as visual assessment. (J Am Coll Cardiol Img 2013;6:
600–9) © 2013 by the American College of Cardiology Foundation
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601yocardial ischemia affects the subendo-
cardial layers of the left ventricular
(LV) myocardium earlier and more se-
verely than the outer layers (1). The
igh spatial resolution of myocardial perfusion car-
iac magnetic resonance (CMR) allows the visual-
zation of subendocardial ischemia as a delayed
ash-in of the contrast agent (2– 4). Post-
rocessing of perfusion CMR data can be used to
uantify the imbalances between subendocardial
nd subepicardial myocardial perfusion. A novel
ethod for semiautomated quantitative analysis of
ransmural perfusion gradients (TPG) has previously
emonstrated a clear distinction between ischemic and
ormally perfused myocardium, with good reproduc-
bility and good correlation with invasive coronary
ngiography (5). However, the diagnostic accuracy of
yocardial TPG analysis against an appropriate func-
ional endpoint has not been established yet.
See page 610
Pressure wire–derived fractional flow reserve
(FFR) is considered the invasive reference standard
for assessing the functional significance of coronary
stenoses and a better comparator for ischemia as-
sessment than anatomical coronary angiography.
The objective of this study was to determine
whether TPG analysis can detect hemodynamically
significant coronary artery disease (CAD) as de-
fined by FFR in a prospective cohort of patients.
M E T H O D S
This study enrolled patients with suspected or known
CAD. A first cohort of retrospectively enrolled pa-
tients were examined with a standard CMR perfusion
protocol and underwent invasive coronary angiogra-
United Kingdom; §Department of Cardiolo
Cardiovascular Research (DZHK, Partner Site)
Pietra Ligure, Italy; ¶Philips Healthcare, Imagin
Image Analysis, Eindhoven University of Techn
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CMR (Group 1). Group 1 was used to
identify the optimal thresholds of TPG for
the detection of hemodynamically signifi-
cant CAD defined by FFR0.8 (6) on both
per-vessel and a per-patient analysis. Ac-
ording to clinical practice in our institution,
FR was performed in all vessels with
50% luminal stenosis. Total coronary oc-
lusions were regarded as significant lesions.
esions with50% luminal stenosis or with
50% stenosis but FFR 0.8 were consid-
red not significant.
The optimal threshold derived in Group 1
as subsequently applied to a prospective ver-
fication group (Group 2) of consecutive pa-
ients listed for coronary angiography by clin-
cal indication. All patients in Group 2
nderwent perfusion CMR as part of the
urrent study prior to coronary angiography.
Exclusion criteria were contraindica-
ions for CMR or gadolinium-based con-
rast agents, history of previous myocardial
nfarction, coronary artery bypass grafting,
cute coronary syndrome, impaired LV function
ejection fraction 40%), and obstructive pulmo-
ary disease. All subjects gave written informed
onsent in accordance with ethical approval. This
tudy complies with the Declaration of Helsinki.
CMR protocol. CMR was performed at 3.0-T
(Achieva-TX, Philips Healthcare, Best, the Neth-
erlands) using a cardiac phased-array receiver coil.
Perfusion data were acquired in 3 LV short-axis
slices with a saturation-recovery gradient-echo
method (repetition time/echo time 3.0 ms/1.0 ms,
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6021.2  1.2  10 mm3) during adenosine-induced
yperemia (140 g/kg/min) and 15 min later at rest
sing 0.05 mmol/kg of bodyweight gadolinium
xtracellular contrast agent (Magnevist, Bayer
chering Pharma, Berlin, Germany) injected at 4
l/s followed by a 20-ml saline flush. Late gado-
inium enhancement images were acquired 15 min
fter contrast was topped-up to a total dose of 0.2
mol of gadolinium/kg of bodyweight (6).
Visual assessment of CMR perfusion. Studies were
nalyzed by 2 independent experts blinded to all
ther data (ViewForum, Philips Healthcare). A
erfusion abnormality was defined as a delayed
ash-in of the contrast agent in 1 or more segments
ompared with remote myocardium according to
ublished methods (3). In case of disagreement
etween observers, the images were reviewed to-
ether and a consensus was reached.
TPG analysis. TPG analysis has been previously re-
orted in detail (5). The implementation of high-
esolution signal intensity (SI) analysis in this study
equired accurate respiratory motion correction and
yocardial contour delineation. Respiratory motion
as corrected using affine image registration by max-
mization of the joint correlation between consecutive
ynamics within an automatically determined region
f interest. A temporal maximum intensity projection
as then calculated to serve as a feature image for an
utomatic contour delineation method (5). The auto-
Figure 1. Schematic Representation of TPG Analysis
(A) After accurate motion correction and image registration, high-re
(endo) and epicardial (epi) contour. By means of bilinear interpolati
ments per slice. (B) The algorithm calculates the intensity of the gr
averaging of the SI of the inner (Iendo) and outer third (Iepi) of the L
results are displayed on the gradientogram plot. The intensity of th
(y-axis) and for each temporal dynamic (x-axis). Increasing endocard
level, so that an endocardial perfusion defect generates a dark are
different percentage thresholds of the gradient’s amplitude. In this
perfusion gradient (green area). LV  left ventricular; SI  signal inatically generated contours were then optimizedisually by the operator to carefully avoid areas of
artial volume effect at the endocardial and epicardial
order. The time required to optimize the segmenta-
ion and complete the TPG analysis time was re-
orded in the first 20 cases.
Following motion correction and contour delin-
ation and optimization, myocardial SI curves were
ampled using bilinear interpolation at a grid of 60
ngular positions (Fig. 1).
The subendocardial and subepicardial SI curves,
endo(,t) and Iepi(,t) were obtained from the inner
and outer thirds of the LV myocardium, ignoring
the mid-wall layers to improve sensitivity to trans-
mural differences in contrast uptake. The TPG
curves G(a,t) were calculated based on the difference
n myocardial SI values in the subendocardial and
ubepicardial layers for each dynamic t, normalized
o the average transmural SI Itransm(,t) in the same
yocardial location , and were expressed in per-
entage of transmural myocardial blood flow
MBF) redistribution (Equation 1).
G(a, t)
Iepi(, t) Iendo(, t)
Itransm(, t)
·100%
The normalized TPG curves represent the evolu-
tion of transmural gradients in contrast uptake over
time.
To avoid analysis errors due to respiratory artifacts, the
tion perfusion series are segmented by drawing the endocardial
data are resampled in 10 transmural layers and 60 radial seg-
nt G in each angular () and temporal position (t) by the spatial
all, normalized by the average transmural SI (Itrasm) (B). (C) The
adient is represented by the gray level in each radial segment
to epicardial gradients are represented with a darkening gray
the gradientogram. (D) The gradientogram can be segmented at
, an intensity threshold of 20% identiﬁes a signiﬁcant transmural
sity; TPG  transmural perfusion gradient.solu
on,
adie
V w
e gr
ial
a in
caseTPG analysis was restricted to the dynamic images
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603starting with the upslope of the SI in the LV (T-onset)
to the 15 following heartbeats (T-onset15s).
Ischemic areas are detected based on the intensity
of the TPG, which represents the difference in
transmural perfusion between the endocardial and
the epicardial layers (Fig. 2). TPG threshold values
of 10%, 15%, 20%, and 25% were tested in Group
1. Each detected TPG was assigned to a coronary
perfusion territory on the basis of the standardized
LV segmentation (7) and compared with FFR. The
best threshold identified on the receiver-operating
characteristic (ROC) analysis in Group 1 was ap-
plied to Group 2 to verify its diagnostic accuracy in
an independent population of patients. Intraob-
server and interobserver variability of TPG analysis
was assessed in Group 2 by comparing the results
obtained by 2 operators blinded to the clinical and
invasive data.
Catheter laboratory protocol. Invasive coronary an-
iography was performed with standard methods
8). FFR was measured in all vessels that showed a
50% diameter stenosis in 2 orthogonal views
uring intracoronary adenosine-induced hyperemia
140 g/kg/min) with a 0.014-inch coronary pres-
Figure 2. Example of TPG Analysis
Upper series, left to right: apical, mid-ventricular, and basal perfus
asterisks indicate a subendocardial perfusion defect in the inferior
are sampled in the radial direction starting from the 0° position, clo
on a 15% threshold showing green areas of inducible TPG correspo
images. The angular position is represented on the y-axis. The time
from the SI upslope in the left ventricle (T-onset) to the 15 followin
nance; other abbreviations as in Figure 1.ure sensor–tipped wire (Volcano Therapeutics, San (iego, California or St. Jude Medical, St. Paul,
innesota) (9).
Statistical analysis. Data were analyzed in a per-patient
nd per-vessel analysis. Data are presented as mean 
D. Group means were compared using an unpaired
tudent t test. Categorical data were compared between
roups using the Fischer exact test and Pearson chi-
quare test, as appropriate. ROC analysis was used to
ssess the diagnostic accuracy of TPG analysis and to
etermine the best TPG threshold. This was de-
ned as the threshold with the highest sum of
ensitivity and specificity. ROC analysis has been
erformed using log-transformed data. ROC curves
ere compared using the DeLong test (Medcalc,
edcalc Software, Ostend, Belgium). Linear re-
ression was used for correlation of TPG with FFR.
ohen’s kappa was used to assess the intraobserver
nd interobserver reliability of qualitative (categor-
cal) TPG results. Because 3 coronary artery terri-
ories were examined per patient, the intraclass
orrelation coefficient was calculated to determine
he design effect and the need to adjust these data
or clustering. The statistical analyses were per-
ormed using PASW software for Macintosh
images at peak enhancement during ﬁrst pass of gadolinium. The
ents (no ischemia was seen on the apical slice in this case). Data
ise. Lower series, left to right: gradientogram plots segmented
ng to areas of subendocardial ischemia in the corresponding CMR
represents the evolution of the transmural perfusion gradient
ynamic images (T-onset15s). CMR  cardiac magnetic reso-ion
segm
ckw
ndi
axis
g dIBM, Chicago, Illinois).
G
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604R E S U L T S
CMR imaging. Thirty patients were enrolled in
Group 1 and 37 patients in Group 2. The groups
showed no difference in baseline demographics
(Table 1).
Table 2. Angiographic Findings in Both Patients’ Cohorts
Per-Vessel Analysis
Group
(90 Vess
Vessels FFR measured 35/90 (3
Vessels with FFR 0.80 22/35 (6
Vessels with FFR 0.80 13/35 (3
FFR negative vessels 0.89 0
FFR positive vessels 0.58 0
Vessels with FFR 0.80
LAD 8/13 (6
RCA 4/13 (3
LCX 1/13 (8
Vessels with chronic total occlusion 2/90 (2
Per-Patient Analysis
Group
(n  30
Time from CMR scan, day 32 2
Vessels FFR measured 1.17 1
No signiﬁcant CAD 6/30 (2
1-Vessel disease 11/30 (3
2-Vessel disease 7/30 (2
3-Vessel disease 4/30 (1
Values are n/N (%) of each group or mean  SD.
CAD  coronary artery disease; CMR  cardiac magnetic resonance: FFR  f
Table 1. Baseline Demographics of Patient Cohorts
Group 1
(n  30)
Group 2
(n  37) p Value
Male 22 (73) 31 (84) 0.48
Age, yrs 59 11 62 8 0.16
Previous PCI 6 (20) 7 (19) 1.00
DM 8 (27) 9 (24) 0.69
Previous stroke 2 (7) 1 (3) 0.61
PVD 2 (7) 3 (9) 1.00
Smoker 8 (27) 8 (22) 0.56
Family history of CAD 9 (30) 10 (27) 1.00
Medications
Statin 23 (77) 30 (81) 0.67
Beta-blocker 13 (43) 19 (51) 0.43
Aspirin 27 (90) 32 (86) 0.72
Clopidogrel 14 (47) 17 (46) 1.00
Nitrate 12 (40) 16 (43) 1.00
Calcium channel blocker 6 (20) 8 (22) 1.00
Nicorandil 1 (3) 2 (5) 1.00
Values are n (%) or mean  SD.
CAD coronary artery disease; DM diabetes mellitus; PCI percutaneous
coronary interventions; PVD  peripheral vascular disease.circumﬂex coronary artery; RCA  right coronary artery.Coronary angiography and FFR. Angiography was
performed within 33  26 days from the CMR
study in Group 1 and 2.6  5.1 days after CMR in
roup 2, reflecting the different enrollment strate-
ies (p  0.001). Of the 90 vessels analyzed in
Group 1, 35 (39%) showed a stenosis of more than
50% and were thus evaluated with FFR. Two
vessels were chronically occluded in Group 1. Thir-
teen lesions had an FFR0.8 (0.58 0.17) and 22
lesions had an FFR 0.8 (0.89 0.05; p 0.001).
In Group 2, 2 vessels were occluded and 42 of 111
vessels showed a visual stenosis 50% and were
evaluated with FFR. Of these, 21 (50%) had FFR
0.80 (0.58  0.16) and 21 (50%) had FFR 0.80
(0.90  0.05; p  0.001). No differences were
found in the distribution and severity of the coro-
nary lesions between the 2 groups (Table 2).
Visual assessment. When applied to Group 1, visual
analysis yielded a sensitivity of 0.81 (95% confi-
dence interval: 0.54 to 0.95), a specificity of 0.91
(0.81 to 0.96), positive predictive value (PPV) of
0.65 (0.41 to 0.84), and negative predictive value
(NPV) of 0.96 (0.87 to 0.99) to detect coronary
ischemia at a FFR 0.8, with an area under the
ROC curve (AUC) of 0.9 (0.68 to 0.96) for
vessel-based analysis. For patient-based analysis,
visual assessment yielded a sensitivity of 0.92 (0.6 to
0.99), a specificity of 0.83 (0.58 to 0.96), a PPV of
Group 2
(111 Vessels) p Value
42/111 (38) 0.84
21/42 (50) 0.37
21/42 (50) 0.42
0.90 0.05 0.44
0.58 0.16 0.95
12/21 (57) 0.78
6/21 (29) 1.00
3/21 (14) 0.62
2/111 (1.8) 1.00
Group 2
(n  37) p Value
2.5 5 0.001
1.14 0.8 0.85
6/37 (16) 0.75
18/37 (49) 0.39
9/37 (24) 1.00
2/37 (5) 0.22
onal ﬂow reserve; LAD  left anterior descending coronary artery; LCX  left1
els)
9)
3)
7)
.05
.17
2)
1)
)
.2)
1
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0)
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6050.79 (0.5 to 0.94), and a NPV of 0.94 (0.68 to 0.99)
with an AUC of 0.86 (0.61 to 0.96). Similar results
were found in Group 2, with a sensitivity of 0.78 (0.6
to 0.92), a specificity of 0.91 (0.82 to 0.96), a PPV of
0.69 (0.5 to 0.84), and a NPV of 0.94 (0.86 to 0.97)
with an AUC of 0.85 (0.78 to 0.94) for vessel-based
analysis, and a sensitivity of 0.89 (0.65 to 0.91), a
specificity of 0.83 (0.58 to 0.96), a PPV of 0.85 (0.61
to 0.96), and a NPV of 0.88 (0.62 to 0.97) with an
AUC of 0.86 (0.8 to 0.93) for patient-based analysis.
TPG analysis versus FFR. The analysis time for TPG
quantitation was 5.4  3.1 min per case. The main
user interaction during TPG analysis was required
to correct for imperfections in the automated image
registration and segmentation, and to avoid partial
volume effects at the endocardial and epicardial
border.
For vessel-based analysis in Group 1, a threshold
of 20% provided the optimal sensitivity (0.81; 0.54
to 0.95) and specificity (0.95; 0.86 to 0.98) to detect
significant coronary lesions (AUC: 0.88; 0.76 to 1).
The 20% threshold yielded the best sensitivity
(0.75; 0.43 to 0.93) and specificity (0.78; 0.52 to
0.92) to detect significant coronary lesions in Group
1 (AUC: 0.76; 0.58 to 0.95) also for patient-based
analysis. Lower and higher threshold values gave
less accurate results.
When applied to Group 2, the 20% threshold
yielded the following results: sensitivity 0.78 (0.56
to 0.92), specificity 0.94 (0.87 to 0.98), PPV 0.78
(0.56 to 0.92), NPV 0.91 (0.82 to 0.96), and AUC
0.86 (0.76 to 0.97) for a per-vessel analysis, and
sensitivity 0.89 (0.65 to 0.91), specificity 0.83 (0.58
to 0.96), PPV 0.85 (0.61 to 0.96), NPV 0.88 (0.62
to 0.98), and AUC 0.86 (0.73 to 0.99) (Fig. 3) for
a per-patient analysis. TPG analysis had similar
diagnostic accuracy to visual assessment on both a
per-vessel and a per-patient analysis (p  0.89 and
p  1, respectively).
Segments supplied by vessels with FFR0.8 had
higher TPG values (30  14%) compared with
segments supplied by vessels with FFR0.8 (7.9
6.9%; p  0.0001) and vessels with no lesions or
angiographic lesions 50% (5.5  6.8%; p 
0.0001). No differences in TPG values were ob-
served when comparing these last 2 groups (p 
0.17).
In vessels with high-grade coronary stenosis
(FFR values of 0.3 to 0.35; n  6), the average
PG was 36  9% (range 24% to 42%). In vessels
with chronic total occlusion (n  5), the measuredPG was 57  25% (range 22% to 84%) (Fig. 4).Linear regression analysis showed a relationship
between TPG and FFR values, with r  0.63 (0.47
to 0.75; p  0.0001) (Fig. 5).
Vessels supplying gradient-positive perfusion ter-
ritories had FFR values significantly lower than
gradient-negative perfusion territories (0.59  0.2
vs. 0.86  0.12, respectively; p  0.001).
When comparing TPG analysis and visual as-
sessment, the results were discordant in 4 patients
in Group 2, with 2 false positives for each method:
1 patient with single-vessel disease (right coronary
artery [RCA], FFR 0.94) and 1 patient with
2-vessel disease (left anterior descending coronary
artery [LAD] and RCA, FFR 0.91 and 0.84,
respectively) for TPG analysis and 1 patient with
single-vessel disease (LAD, FFR 0.9) and 1 patient
with 2-vessel disease (LAD and RCA, FFR 0.87
and 1, respectively) for visual assessment.
TPG analysis showed a good intraobserver and
interobserver agreement for both vessel-based ( 
0.84; 0.76 to 1, and   0.72; 0.50 to 0.95,
espectively) and patient-based analyses (  0.79;
.72 to 0.96, and   0.69; 0.49 to 0.91, respec-
tively). The intra-assay of the coefficient of variation
of gradients positivity was 4% (p  0.32) when
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606Four patients (2 in each group) had evidence of
subendocardial myocardial infarction on late
gadolinium-enhanced images. In 1 case, the pres-
ence of subendocardial scar caused a false-positive
TPG detected by the algorithm at thresholds of
10% and 15%. No false-positive TPG were identi-
fied at the threshold of 20%.
D I S C U S S I O N
The main findings of this study are: 1) quantitative
TPG analysis of stress myocardial perfusion CMR
data can be used to detect and localize hemodynam-
ically significant CAD as defined by FFR; 2) a 20%
TPG provides the optimal threshold for the detec-
tion of significant CAD for both vessel- and
patient-based analyses; and 3) a 20% TPG has a
similar diagnostic accuracy as visual assessment of
perfusion CMR images.
Previous studies. The detection of subendocardial
ischemia is considered a sensitive endpoint for the
diagnosis of pathological alterations of myocardial
blood supply (2,4,10–13). Previous studies have used
single-photon emission computed tomography
(SPECT) and positron emission tomography to mea-
sure the transmural perfusion ratio. Due to the rela-
tively low spatial resolution of nuclear myocardial
perfusion imaging, these studies have been limited to
patients with LV hypertrophy (4,14–17). Only a few
studies using 15O-labeled water positron emission
omography reported a transmural perfusion ratio in
CTO FFR < 0.8 FFR ≥ 0.8 Stenosis < 50%
Showing the Distribution of TPG Values According to the
PG values was observed for increasing degrees of severity of coro-
gments supplied by vessels with FFR 0.8 had higher TPG values
nts supplied by vessels with FFR 0.8 and vessels with no lesions
s 50%. The highest TPG values were measured in vessels with
(CTO). FFR  fractional ﬂow reserve; TPG  transmural perfusionormal hearts in animal experiments and in healthyolunteers (4), confirming the existence of transmural
erfusion inhomogeneities also in normal hearts, with
igher rest MBF in the subendocardium and a ho-
ogeneous MBF during stress.
Two studies have used the higher spatial resolu-
ion of multislice computed tomography (MSCT)
o delineate transmural perfusion gradients. George
t al. (18) described transmural differences in the
ttenuation density in the subendocardial and sub-
picardial layers of the LV during adenosine stress
SCT. Signals were sampled from a single perfu-
ion image in the inner and outer thirds of the LV
all. The transmural perfusion ratio was inversely
orrelated with the percent diameter stenosis, provid-
ng functional information complementary to the
natomic diagnostic information by MSCT coronary
ngiography (18). Hosokawa et al. (19) compared
SCT-detected transmural perfusion abnormalities
ith SPECT and invasive coronary angiography.
SCT-derived transmural perfusion gradients were
efined as the difference in attenuation density be-
ween the subendocardial and subepicardial layers,
ormalized to the LV wall thickness (Hounsfield
nit/mm). The transmural perfusion gradients corre-
ated with the severity of myocardial perfusion abnor-
alities detected by SPECT and yielded a higher
iagnostic accuracy than SPECT compared with in-
asive coronary angiography.
The main advantages of CMR are its high spatial
esolution and tissue contrast, and the lack of
onizing radiation (20). Previous studies have re-
orted the use of the transmural perfusion ratio to
xplore the physiological transmural gradient of
yocardial perfusion in healthy subjects (10,21)
nd to investigate the presence of ischemia in
atients with syndrome X (2,12,22), cardiac trans-
lant arteriopathy (11), and systemic inflammatory
iseases (23,24). In these studies, CMR findings
ave been compared with coronary angiography
natomical findings (11,22,23), visual (22,24) or
emiquantitative CMR perfusion indexes (2,12,23),
nd only in a few studies against MBF quantifica-
ion (10,21) or invasive coronary flow reserve mea-
urements (11). All these studies but 1 (12) con-
rmed the relevance of subendocardial ischemia for
he functional assessment of inducible perfusion
bnormalities.
Present study. Our study confirms the diagnostic
potential of TPG analysis and adds to the literature
in several aspects. This is the first study to our
knowledge validating subendocardial ischemia de-
tection against FFR. All previous studies usedTP
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607although it is well documented that the functional
relevance of a given stenosis varies widely (25).
Recently, quantitative MBF analysis has become
a widely adopted investigational method in the
literature and high-resolution quantitative analysis
is a competing technique with TPG analysis for the
identification of subendocardial ischemia (26,27).
However, the accuracy of MBF quantification can
be affected by sampling errors in the arterial input
function, by dispersion of the bolus of contrast
exacerbated by an epicardial stenosis and by system-
atic errors in the fitting procedure required to
calculate the MBF estimates (28). The TPG anal-
ysis has several practical advantages over MBF
quantification. Unlike most other semiquantitative
or quantitative analysis methods, it does not require
administration of a diluted pre-bolus or the acqui-
sition of rest perfusion images and is potentially
more robust. Because TPG are normalized to the
average transmural myocardial SI, the measure-
ments are relatively insensitive to image inhomoge-
neities due to variations in the B1 field and different
coil configurations, different schemes of contrast
agent administration, field strength, and the acqui-
sition pulse sequence (5). In the current study, this
was reflected in the high interobserver reproducibil-
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Figure 5. Scatterplot Showing the Distribution of TPG Values A
Linear regression analysis showed a relationship between TPG and
eral ﬂow, microvascular reactivity, myocardial contractile function a
modulate the relationship between TPG and FFR and can explain th
p  0.0001). Abbreviations as in Figure 4.ity. Other analysis techniques, such as MBF quan- stification, are on the other hand more susceptible to
field inhomogeneities (10).
Finally, unlike MSCT and nuclear techniques,
the gradientogram method integrates the infor-
mation acquired over the entire first myocardial
contrast passage. This allows the visualization of
the temporal evolution of the TPG from the
upslope of signal in the LV cavity (T-onset) to
the following 15 dynamics (T-onset15s). This
property, as well as the use of a threshold of
intensity of the TPG as main diagnostic criterion,
allows an effective filtering of the noise contained
in the images that could be responsible for false
positives, resulting in a good specificity on per-
vessel analysis at the cost of some false negatives.
However, on a per-patient analysis, this property
allowed a good diagnostic accuracy with balanced
sensitivity and specificity.
A transmural redistribution of myocardial perfu-
sion of 20% resulted in being the most accurate
TPG threshold to detect hemodynamically signifi-
cant CAD with very good diagnostic accuracy in
both groups.
Study limitations. A theoretical limitation of TPG
ethods is that they may be false normal in the
resence of high-grade coronary stenosis with con-
0.5 0.4 0.3 0.2 0.1 0
R = 0.63
P < 0.001
 Value
False Negatives
True Positives
ding to FFR
values. Several physiological factors such as the amount of collat-
he presence of subendocardial scar are in principle capable to
bserved degree of correlation, with r  0.63 (0.47 to 0.75;FFR
ccor
FFR
nd t
e oequent transmural ischemia. Interestingly, this sit-
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608uation did not arise in our patients, despite the
presence of subjects with high-grade coronary ste-
noses and FFR values as low as 0.3, and patients
with chronic coronary occlusions, for whom a visu-
ally transmural perfusion abnormality was reported.
This suggests that even high-grade stenoses do not
cause truly transmural perfusion defects and that
this can be demonstrated with TPG analysis if the
source data have sufficient spatial and temporal
resolution. Future studies will be required to dem-
onstrate the feasibility of transmural perfusion gra-
dient analysis also at 1.5-T with a lower in-plane
spatial resolution. Future studies also need to eval-
uate the impact of collateral flow on TPG.
We have used a FFR cutoff of 0.8 (29), but 0.75
is also clinically used to define the significance of a
coronary stenosis. We repeated the analysis for a
cutoff of 0.75 (data not shown) without significant
differences in the findings.
Our patient population had high disease preva-
lence, and future studies need to test the TPG
method in other patient groups. We also excluded
patients with a history of myocardial infarction
because measurements of FFR in the infarct-related
artery may potentially be biased for 2 reasons: 1) the
mass of viable myocardium depending on the ste-
notic infarct-related artery is smaller for a similar
degree of stenosis and 2) microvascular resistance
may be greater in the infarcted area than in thephy. J Nucl Cardiol 2011;18:650–6. when calculating femia (30). This choice has resulted in a very low
prevalence of myocardial scar on late gadolinium
enhancement images in the current study popula-
tion. Areas of subendocardial scar are likely to
generate false-positive TPG. This was observed in 1
case in Group 1, where an area of inferolateral
subendocardial scar resulted in a positive gradient
for thresholds between 10% and 15%. No false-
positive gradients were observed for the 20%
threshold.
Our results also demonstrate a significant corre-
lation between TPG and FFR values. However,
several physiological factors such as the amount of
collateral flow, microvascular reactivity, and myo-
cardial contractile function are in principle capable
to modulate the relationship between TPG and
FFR and can explain the observed degree of corre-
lation (r  0.63).
C O N C L U S I O N S
The quantitative analysis of transmural perfusion
gradients on high-resolution CMR accurately pre-
dicts hemodynamically significant CAD as defined
by FFR.
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